These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261 [TBL] [Abstract][Full Text] [Related]
5. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154 [TBL] [Abstract][Full Text] [Related]
6. [The significance of autoantibodies coexisting with anti-centromere antibodies in sera of patients with primary biliary cirrhosis]. Moteki S; Yoshida H; Nishimaki T; Morito T Rinsho Byori; 1990 Aug; 38(8):888-94. PubMed ID: 2232249 [TBL] [Abstract][Full Text] [Related]
7. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis. Vázquez-Abad D; Grodzicky T; Senécal JL Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829 [TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis]. Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074 [TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome. Katano K; Kawano M; Koni I; Sugai S; Muro Y J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163 [TBL] [Abstract][Full Text] [Related]
11. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)]. Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303 [TBL] [Abstract][Full Text] [Related]
12. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Russo K; Hoch S; Dima C; Varga J; Teodorescu M J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030 [TBL] [Abstract][Full Text] [Related]
13. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma). Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases. Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202 [TBL] [Abstract][Full Text] [Related]
15. Anti-centromere autoantibody in a patient evolving from a lupus/Sjögren's overlap to the CREST variant of scleroderma. Ford AL; Kurien BT; Harley JB; Scofield RH J Rheumatol; 1998 Jul; 25(7):1419-24. PubMed ID: 9676778 [TBL] [Abstract][Full Text] [Related]
16. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La. Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of patients with both anti-U1RNP and anti-centromere antibodies. Takada K; Suzuki K; Matsumoto M; Okada M; Nakanishi T; Horikoshi H; Higuchi T; Ohsuzu F Scand J Rheumatol; 2008; 37(5):360-4. PubMed ID: 18686191 [TBL] [Abstract][Full Text] [Related]
18. Clinical and serological hallmarks of systemic sclerosis overlap syndromes. Pakozdi A; Nihtyanova S; Moinzadeh P; Ong VH; Black CM; Denton CP J Rheumatol; 2011 Nov; 38(11):2406-9. PubMed ID: 21844148 [TBL] [Abstract][Full Text] [Related]
19. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [TBL] [Abstract][Full Text] [Related]
20. [Association of systemic lupus erythematosus and Sjögren's syndrome]. Szántó A; Kiss E; Sas A; Szegedi G; Zeher M Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]